DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS

Simple item page
dc.contributor.authorKoca, SS
dc.contributor.authorPehlivan, Y
dc.contributor.authorAkar, S
dc.contributor.authorSenel, S
dc.contributor.authorKaradeniz, H
dc.contributor.authorSosyal, O
dc.contributor.authorYazici, A
dc.contributor.authorYilmaz, S
dc.contributor.authorSagir, RP
dc.contributor.authorInanc, N
dc.contributor.authorKaratas, A
dc.contributor.authorCetin, GY
dc.contributor.authorOnen, F
dc.date.accessioned2024-07-18T12:07:57Z
dc.date.available2024-07-18T12:07:57Z
dc.identifier.issn0003-4967
dc.identifier.other1468-2060
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10727
dc.language.isoEnglish
dc.publisherBMJ PUBLISHING GROUP
dc.titleDISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu